Heterogeneous nuclear ribonucleoprotein C pseudogene 1 (HNRNPCP1)

HNRNPCP1 is classified as a pseudogene, meaning it closely resembles the functional HNRNPC gene that encodes a ribonucleoprotein involved in RNA processing, but HNRNPCP1 itself does not encode a functional protein, and there is no evidence it is involved in biological pathways, disease mechanisms, or as a drug target. The functional HNRNPC is distinct and plays major roles in RNA processing, but references to “HNRNPCP1” in the context of receptors, enzymes, or drug targets are incorrect because pseudogenes are generally not expressed as functional proteins. Essential context and supporting details: - Pseudogenes like HNRNPCP1 arise from duplication or retrotransposition events that leave a sequence similar to an existing gene, but typically lack regulatory elements, have mutations, and are not transcribed or translated into functional proteins. - HNRNPCP1 is not a target in clinical pharmacology, therapeutic intervention, or diagnostic strategy. There are no documented biological functions, disease associations, drug interactions, or safety concerns linked to it. - The biologically functional and clinically relevant gene is HNRNPC (Heterogeneous nuclear ribonucleoprotein C), not HNRNPCP1. - References to the biological activities (e.g., RNA splicing, cell cycle regulation, disease association) describe the functional HNRNPC gene, not its pseudogene derivative[4][5]. Summary of status: - HNRNPCP1 should not be considered a receptor, enzyme, transporter, transcription factor, or therapeutic target. - The presence of "pseudogene" in its name signals it is not a functional entity in molecular biology, pharmacology, or medicine. If you intended to ask about the functional gene or protein HNRNPC (without the "pseudogene 1" distinction), please clarify; otherwise, HNRNPCP1 is not a target of pharmacological or clinical interest.

Other names

hnRNPC pseudogene 1HNRNPCP1